Dr Jo Tod

Consultant Gastroenterologist & Hepatologist

Specialties

Gastroenterology
Hepatology

I graduated from Imperial College London in 2004 with distinction.

I completed my Gastroenterology training in Wessex & undertook an advanced specialist Hepatology fellowship at University Hospital Southampton gaining liver transplant experience at Addenbrooke's Hospital, Cambridge. In addition to Hepatology I have a subspecialist interest in Pancreatology having completed the European Pancreas 2000 program & gained a Diploma in Pancreatology.

During my post graduate training I was awarded an MRC Fellowship & completed a PhD investigating mechanisms of invasion in Pancreatic Cancer. I was subsequently appointed as an NIHR Academic Clinical Lecturer where I continued my research in Pancreatic adenocarcinomas in addition to Pancreatic neuroendocrine tumours alongside my clinical training. I have published my research in peer reviewed journals.

I returned to full-time clinical practice in 2018 & was appointed as a Consultant Gastroenterologist & Hepatologist at Bournemouth Hospital in 2019.

What people can be referred for

Deranged LFTs, jaundice, cirrhosis, fatty liver, autoimmune & metabolic liver conditions, viral hepatitis, hepatocellular carcinoma, pancreatic conditions, neuroendocrine tumours as part of the multi-disciplinary team.

Why I chose my specialties

I love the variety of conditions, range of clinical presentations & diagnostic challenges seen in Hepatology.

Primary contact

Secretaries: Jasmine Klughardt 

0300 019 4893

Membership of professional bodies

GMC, BSG, BASL

Year of registration

2004

Special clinical interests

Cirrhosis
Portal hypertension
Hepatocellular carcinoma
Autoimmune & metabolic liver disease
Non-alcoholic fatty liver disease/NASH
Pancreatology
Gastrointestinal neuroendocrine tumours

Publications

Pro-migratory and TGF-B-activating functions of alpha-v beta-6 integrin are differentially regulated via an Eps8-dependent GTPase switch in Pancreatic Cancer - Tod J, Hanley CJ, Morgan MR, Rucka M, Mellows T, Lopez MA, Kiely P, Moutasim KA, Frampton SJ, Sabnis D, Fine DR, Johnson C, Marshall JF, Scita G, Jenei V, Thomas GJ - Journal of Pathology 2017; 243:37-50

Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis - M Mellone*, Chris Hanley*, T Mellows, E Sayan, J Tod, F Noble, T Underwood, A Mirnezami, M Bullock, Lambert, SS Prime, GJ Thomas - Aging 2016 Dec 15; 9(1):114-132

Periductal stromal collagen topology of pancreatic ductal adenocarcinoma differs from that of normal and chronic pancreatitis - Cole Drifka, Jo Tod, Agnes Loeffler, Yuming Liu, Gareth Thomas, Kevin Eliceiri, W. John Kao - Modern Pathology 2015 Nov;28(11):1470-80.

Systematic Review and Meta-Analysis of Immunohistochemical Prognostic Biomarkers in Resected Oesophageal Adenocarcinoma - L.M. Matthews, F. Noble, J. Tod, E. Jaynes, S. Harris, J.N Primrose, C. Ottensmeier, G.J Thomas, T. Underwood - British Journal of Cancer 2015, June 30; 113(1):107-18

Suppression of hedgehog signalling promotes pro-tumourigenic integrin expression and function - Moutasim KA, Mellows T, Mellone M, Lopez MA, Tod J, Kiely PC, Sapienza K, Greco A, Neill GW, Violette S, Weinreb PH, Marshall JF, Ottensmeier CH, Sayan AE, Jenei V, Thomas GJ. - Journal of Pathology 2014. Jun;233(2):196-208.

Tumor-stromal interactions in pancreatic cancer - J. Tod, V. Jenei, D. Fine, G. Thomas - Review paper, Pancreatology Jan/Feb 2013(13):1-7

Fecal elastase: A useful test in pancreatic Insufficiency? - J. Tod, D. Fine - Editorial, Digestive Disease and Sciences 2010: Oct;55(10):2709-11

Research

Portal Hypertension
Cirrhosis